Endologix Comments on Alleged Patent Infringement
October 08 2009 - 7:35PM
PR Newswire (US)
IRVINE, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Endologix, Inc.
(NASDAQ: ELGX), developer of minimally invasive treatments for
aortic disorders, acknowledged today that it has become aware that
Cook Medical has filed a lawsuit against Endologix in the United
States District Court alleging that Endologix infringes two of
Cook's U.S. patents. John McDermott, Endologix President and Chief
Executive Officer, said, "We have just become aware of the lawsuit
filed by Cook alleging that Endologix infringes two of Cook's
patents, one of which was granted in 1991 and the other in 1998.
The patent granted in 1991 expires next week. Together with our
patent counsel, we are conducting a thorough evaluation and will
provide more information as soon as available." About Endologix,
Inc. Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's flagship product is
the Powerlink® System, which is an endovascular stent graft for the
treatment of abdominal aortic aneurysms (AAA). AAA is a weakening
of the wall of the aorta, the largest artery in the body, resulting
in a balloon-like enlargement. Once AAA develops, it continues to
enlarge and, if left untreated, becomes increasingly susceptible to
rupture. Additional information can be found on Endologix's Web
site at http://www.endologix.com/. Forward-Looking Statements
Except for historical information contained herein, this news
release contains forward-looking statements, specifically related
to the alleged claims of infringement. Please refer to the
Company's Annual Report on Form 10-K for the year ended December
31, 2008, and the Company's other filings with the Securities and
Exchange Commission, for more detailed information regarding these
risks and other factors that may cause actual results to differ
materially from those expressed or implied. COMPANY CONTACT:
INVESTOR CONTACTS: Endologix, Inc. The Ruth Group John McDermott,
CEO Nick Laudico (646) 536-7030 (949) 595-7200 Zack Kubow (646)
536-7020 http://www.endologix.com/ DATASOURCE: Endologix, Inc.
CONTACT: John McDermott, CEO, Endologix, Inc., +1-949-595-7200, or
Investors, Nick Laudico, +1-646-536-7030 or Zack Kubow,
+1-646-536-7020, both of The Ruth Group Web Site:
http://www.endologix.com/
Copyright